Consumer Healthcare Products Association
FDANonrulemakingFDA-2023-D-4177

Quality Considerations for Topical Ophthalmic Drug Products; Draft Guidance for Industry; Availability

RIN
Last modified
Feb 4, 2025
Comment window
closed 883d ago
Consumer Healthcare Products Association filings
1

Activity

Consumer Healthcare Products Association filed 1 comment on this docket between Dec 13, 2023 and Dec 13, 2023. 1 other organizations filed here. The comment window closed 883d ago.

What Consumer Healthcare Products Association filed (1)

Dec 13, 2023· Comment from Consumer Healthcare Products Association (CHPA)· FDA-2023-D-4177-0016

Filed on regulations.gov — full text not in the inline record.

Abstract

OPEN

View on regulations.gov →
Quality Considerations for Topical Ophthalmic Drug Products; Draft Guidance for Industry; Availability (FDA) — Consumer Healthcare Products Association | OpenPolis